Varicella Vaccine — Are Two Doses Better Than One?
- 12 December 2002
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 347 (24) , 1962-1963
- https://doi.org/10.1056/nejme020138
Abstract
The live attenuated varicella vaccine was approved by the Food and Drug Administration in 1995 for routine use in healthy persons older than one year of age who are susceptible to varicella. Children are given one dose of vaccine; two doses one to two months apart are given to persons older than 13 years of age. Acceptance of the vaccine in young children has been excellent; currently, more than 75 percent of appropriate children are immunized in the United States. The goal of the Centers for Disease Control and Prevention of reaching more than 90 percent of children less than . . .Keywords
This publication has 7 references indexed in Scilit:
- Outbreak of Varicella at a Day-Care Center despite VaccinationNew England Journal of Medicine, 2002
- Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995-2000JAMA, 2002
- The postmarketing safety profile of varicella vaccineVaccine, 2000
- Postlicensure effectiveness of varicella vaccine during an outbreak in a child care centerPublished by American Medical Association (AMA) ,1997
- The Incidence of Zoster after Immunization with Live Attenuated Varicella VaccineNew England Journal of Medicine, 1991
- Live attenuated varicella vaccine. Efficacy for children with leukemia in remissionJAMA, 1984
- Live Attenuated Varicella Virus VaccineNew England Journal of Medicine, 1984